(Q53548858)
Statements
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. (English)
Glaros S
Cirrincione GM
Muchardt C
Kleer CG
Michael CW
Reisman D
4 June 2007
7058-7066
1 reference
1 reference